February 03, 2016
1 min read
Save

Children’s Hospital Los Angeles names director of Center for Personalized Medicine

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Jaclyn Biegel, PhD, has been named director of the Center for Personalized Medicine at Children’s Hospital Los Angeles.

Biegel ― known for her expertise in pediatric brain tumors, rhabdoid tumors and cancer cytogenetics ― will oversee the development and implementation of new genomic tests for diagnosis and risk assessment for children and families with a variety of genetic disorders and cancer.

Jaclyn Biegel, PhD

Jaclyn Biegel, PhD

“I am very excited to be part of a team that is at the forefront of this revolution in modern medicine,” Biegel said in a press release. “We have recruited an outstanding group of faculty in clinical laboratory genetics and bioinformatics and are well-positioned to launch clinical exome-based testing and comprehensive pediatric cancer gene panels within the next few months.”

Biegel also will serve as professor of pathology at Keck School of Medicine of University of Southern California, as well as chief of the division of genomic medicine at Children’s Hospital Los Angeles (CHLA).

“Dr. Biegel is one of the world’s leading authorities on the molecular genetics of pediatric brain tumors and brings to CHLA an established, outstanding track record in applied genetic research relevant to pediatric disease,” Alexander R. Judkins, MD, FRCP (Edin), executive director of the Center for Personalized Medicine and pathologist-in-chief at CHLA, said in a press release. “We are thrilled to have her join our center, where she will lead and cultivate a multidisciplinary team of physicians, laboratorians, bioinformaticians, and scientists and supporting clinical experts at CHLA to build specialized, targeted health care plans for children based on their individual genomes.”

Biegel previously served as director of the cancer cytogenetics laboratory at The Children’s Hospital of Philadelphia and a professor of pediatrics in Perelman School of Medicine at University of Pennsylvania.